Researchers have developed antibiotics that can potentially kill drug-resistant gonorrhoea and MRSA with the help of artificial intelligence.
The team at the Massachusetts Institute of Technology (MIT) used generative AI algorithms to design more than 36 million molecular compounds, identifying two new drugs that were then tested in lab settings and in mice.